Deadly Explosion at Southern India Pharmaceutical Factory Claims 36 Lives
A catastrophic explosion at a pharmaceutical factory in southern India has resulted in 36 confirmed deaths, prompting state investigations and hospitalizations for numerous injured workers.
Overview
- A deadly explosion occurred at a pharmaceutical factory in Telangana, southern India, resulting in a confirmed death toll of 36 individuals.
- The explosion happened in the spray dryer unit of the factory, with 108 workers present at the time of the incident.
- Rescue operations are ongoing, with debris being cleared to search for any remaining trapped workers.
- Injured workers have been admitted to hospitals, with some suffering severe burns; a special medical team is conducting DNA tests for identification.
- The incident has led to an 8% drop in shares of Sigachi Industries, the company operating the factory, highlighting the economic impact of the tragedy.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
Center-leaning sources present a somber and urgent tone regarding the explosion at the pharmaceutical factory, emphasizing the human toll and the need for accountability. They highlight the injuries and fatalities while framing the incident as a significant tragedy, reflecting a concern for worker safety and the implications of industrial negligence.
The fire department recovered 34 charred bodies of workers from the accident site.
Three workers died in the hospital due to burns.
Nearly three dozen injured workers were admitted to hospitals following a blast.
An explosion and fire occurred in the factory's spray dryer unit on Monday.
A government panel has been established to investigate the cause of the incident or disaster.
Approximately 36 workers were injured in the incident.
Debris is being removed from the gutted pharmaceutical unit of Sigachi Industries to search for any trapped workers.
The plant produces microcrystalline cellulose, a chemical compound used in drug manufacturing.
Health Minister Damodar Raja Narasimha confirmed that there were 108 workers inside the factory during the explosion.
A specialized medical team has been sent to perform DNA testing.
Industrial accidents, especially those involving chemical reactors, are common in factories.
Sigachi Industries' shares fell 8% in intra-day trading on Tuesday and following an incident.
A pharmaceutical factory explosion in Telangana, India, resulted in the deaths of at least 36 people.
Articles (4)
Center (3)
"…The death toll from a massive explosion and fire at a pharmaceutical factory in India’s southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday."
NBC News·16h·"…The death toll from Monday's massive explosion and fire at a pharmaceutical factory in India’s southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday."
ABC News·19h·"…The death toll from Monday’s massive explosion and fire at a pharmaceutical factory in India’s southern state of Telangana has risen to at least 36 while about three dozen were left injured, authorities said Tuesday."
Associated Press·19h·FAQ
The explosion at the Sigachi Industries pharmaceutical factory in Telangana is suspected to have been caused by a chemical reaction.
There were 108 workers present at the time of the explosion, with 36 confirmed deaths and several others injured and hospitalized.
Rescue operations are ongoing with debris being cleared to search for any remaining trapped workers; identification of bodies is underway with DNA tests being conducted.
The explosion has contributed to an 8% drop in shares of Sigachi Industries, indicating significant economic impact on the company.
Survivors have sustained severe burns and head injuries; many are on ventilators, and hospitals have referred some cases to superspeciality facilities for advanced care.
History
- This story does not have any previous versions.